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Introduction {#sec1}
============

Analyses of the human transcriptome using tiling arrays ([@bib4], [@bib17]) and RNA-sequencing (RNA-seq) technology ([@bib2], [@bib11]) have revealed that the entire genome is extensively transcribed as RNA. Substantial fractions of these transcripts are relatively long, apparently do not encode proteins, and are commonly termed "long noncoding RNAs" (lncRNAs). However, the functions of the lncRNAs are not yet well understood. One point of view, in fact, suggests that they mostly represent "transcriptional noise" ([@bib29], [@bib33]). Nonetheless, an increasing body of recent evidence suggests that specific lncRNAs play a regulatory role in numerous cellular processes, including stem cell pluripotency ([@bib12], [@bib23]), cell-cycle regulation ([@bib14]), cell development and differentiation ([@bib20], [@bib21]), and human disease pathogenesis ([@bib37]). Other studies have documented that lncRNAs recruit chromatin modification complexes involved in gene silencing or gene activation. For example, the lncRNAs *Xist* ([@bib38]) and *HOTAIR* ([@bib30], [@bib35]) physically associate with Polycomb repressive complex 2 (PRC2) in the *cis* or *trans* form ([@bib10]) and specifically repress target genes by modulating histone H3 lysine 27 trimethylation (H3K27me3) at various sites along the genome. Similarly, the lncRNAs *HOTTIP* ([@bib36]) activate *HOXA* genes by recruiting the TrxG: MLL1 (Trithorax group activator:Mixed lineage leukemia 1) complex to chromatin, which leads to increased H3K4 trimethylation (H3K4me3) at the *HOXA* locus. A very recent study reported that the lncRNA *ecCEBPA*, which is transcribed in the same direction as the *C/EBPα* gene, interacts with DNMT-1 to block *C/EBPα* gene methylation in leukemic cell lines ([@bib6]).

Obesity is an important risk factor for various diseases, particularly heart disease, diabetes, hypertension, and cancer ([@bib8]). Thus, understanding the molecular mechanism that regulates adipogenesis would be expected to facilitate the development of methods for the treatment of obesity and other adipogenic-differentiation-related disorders. In recent years, human mesenchymal stem cells (hMSCs) have been widely used as an alternative model for the study of human adipogenesis. In contrast to human pre-adipocytes, hMSCs are multipotent, and there is less individual variability between donor-derived hMSCs ([@bib15], [@bib28]). Over the past 2 decades, transcriptional regulation of adipogenesis has been shown to involve an elaborate network of transcription factors that coordinate the expression of several hundred proteins ([@bib7]). *PPARγ* and *C/EBPα* are considered to be the two principal adipogenic transcription factors in this network, positively regulating each other's expression and cooperating in the control of adipogenesis ([@bib31]). Nevertheless, the detailed molecular mechanism that activates the expression of *PPARγ* and *C/EBPα* during adipogenesis is not yet known. Although several lncRNAs are differentially regulated during adipogenesis ([@bib18], [@bib34]), none have been identified to directly participate in the genetic control of adipogenic differentiation. Here, we reveal that, during adipogenic differentiation, an uncharacterized noncoding RNA (*ADINR*) activates the *C/EBPα* gene in *cis* by impacting H3K4me3 and H3K27me3 histone modification of the *C/EBPα* locus. These findings have major implications for obesity and human disease.

Results {#sec2}
=======

*ADINR* Is a lncRNA Upregulated during Adipogenesis {#sec2.1}
---------------------------------------------------

To explore whether lncRNAs are involved in the adipogenic differentiation of hMSCs, we designed a customized microarray to probe the expression profiles of 39,303 human transcripts that have been annotated as potential noncoding RNAs (see [Experimental Procedures](#sec4){ref-type="sec"}). The expression profiles were probed on days 0, 3, and 6 of adipogenic differentiation. Analysis showed that 1,423 annotated or potential lncRNAs were up- or downregulated by \>2-fold during adipogenic differentiation (Student's t test, false discovery rate \[FDR\] \< 0.2; [Figure 1](#fig1){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}). Of these, 37.7% (536) showed reduced expression during differentiation relative to uninduced cells, while the remaining lncRNAs (887) were highly induced at an early (day 3) and/or a late (day 6) stage of adipogenic differentiation. We focused on an uncharacterized RNA transcript, *ADINR*, whose genomic location suggested that it was divergently transcribed from a position ∼450 bp upstream of the *C/EBPα* gene ([Figure 1](#fig1){ref-type="fig"}B). *ADINR* exhibited significantly increased expression on days 3 and 6 (p \< 0.02) compared to undifferentiated hMSCs. Sequence analysis of the *ADINR* locus revealed it to be highly conserved in rhesus macaque, mouse, dog, and elephant ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Furthermore, qRT-PCR showed that *ADINR* expression increased 20- to 30-fold on days 3 and 6 relative to day 0 ([Figure 1](#fig1){ref-type="fig"}C), confirming the microarray data. The qRT-PCR results further showed that *ADINR* and *C/EBPα* are co-expressed during adipogenic differentiation ([Figure 1](#fig1){ref-type="fig"}C). Analysis performed by the 5′ and 3′ rapid amplification of cDNA ends (RACE) suggested that the *ADINR* locus produces two polyadenylated, unspliced transcripts ([Figure 1](#fig1){ref-type="fig"}D; [Figure S1](#mmc1){ref-type="supplementary-material"}B). Isoform A has an ∼190-nt-long extension at the 3′ end relative to isoform B, the latter being the major form as determined by RACE ([Figure 1](#fig1){ref-type="fig"}D), and the primers used are listed in [Figure S1](#mmc1){ref-type="supplementary-material"}C. Additional RT-PCR analyses of multiple human cell lines suggested that *ADINR* is expressed in a number of tissues (lung, liver, colon, etc.) and not restricted to hMSCs and adipocytes ([Figure S1](#mmc1){ref-type="supplementary-material"}D). RNA-seq data from ENCODE indicates that expression of the *ADINR* and *C/EBPα* genes is correlated in all nine cell lines tested ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Single-molecule RNA fluorescence in situ hybridization of *ADINR* showed that the transcript is exclusively localized in the nucleus of hMSCs and day-3 differentiated cells ([Figure 1](#fig1){ref-type="fig"}E).

*ADINR* Regulates the Adipogenesis Program In Vitro and In Vivo {#sec2.2}
---------------------------------------------------------------

To study the functional role of *ADINR* during adipogenesis, we used small interfering RNAs (siRNAs) to knock down *ADINR* transcripts on day 0, followed by culture in hMSC medium (adipogenesis d0) or adipogenic medium for 3 days (adipogenesis d3). Knockdown of *ADINR* with two independent siRNAs markedly reduced the expression of *C/EBPα* and *PPARγ*, both at mRNA and protein levels on day 0 and day 3 ([Figures 2](#fig2){ref-type="fig"}A--2C), suggesting that *ADINR* RNA plays a key role in the coordinated activation of *C/EBPα* and *PPARγ* during adipogenic differentiation. We further transfected the siRNAs (\#1) and depleted *ADINR* in hMSCs on day 0, followed by 8 days of adipogenic differentiation. Notably, knockdown of *ADINR* resulted in a dramatic adipogenic defect, as shown by the decreased number of oil red O^+^ cells and reduced adipogenic transcripts *C/EBPα*, *PPARγ*, fatty acid binding protein 4 (Fabp4) and lipoprotein lipase (LPL; [Figures 2](#fig2){ref-type="fig"}D and 2E; [Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). To exclude the off-target effects of the siRNAs for *ADINR* knockdown, we also performed more knockdown assays using RNase-H-based antisense oligonucleotides (ASO). Likewise, the ASO-targeted *ADINR* could not only downregulate the expression of *C/EBPα*, *PPARγ*, FABP4, and LPL ([Figure 2](#fig2){ref-type="fig"}F) but also decrease the number of oil red O^+^ cells ([Figure 2](#fig2){ref-type="fig"}G).

Subsequently, we tested whether the adipogenic defect could be rescued by ectopic expression of the *ADINR* RNA. To eliminate the possibility that "adipogenic rescue" was caused by the ectopic *ADINR* RNA annealing to the siRNA (\#1) and titrating it away, hMSCs were sequentially transfected with the siRNA (\#1) on day 0 and then infected with a lentivirus expressing a mutant *ADINR* RNA with four mutations in the siRNA target site ([Figure 2](#fig2){ref-type="fig"}H). After dexamethasone treatment for adipogenic differentiation, we found that the ectopic mutant *ADINR* exhibited scant rescue of the severe adipogenic defects caused by the depletion of endogenous *ADINR* ([Figure 2](#fig2){ref-type="fig"}I). This rescue assay only resulted in an ∼1.2- to ∼1.3-fold increase in the expression of *C/EBPα* mRNA as well as other adipogenic markers. However, the adipogenic deficiency was readily rescued by lentivirus-mediated ectopic expression of *C/EBPα* ([Figures 2](#fig2){ref-type="fig"}I and 2J; [Figure S2](#mmc1){ref-type="supplementary-material"}C). In addition, ectopic overexpression of wild-type *ADINR* barely stimulated *C/EBPα* expression and also failed to facilitate the adipogenic differentiation of hMSCs as efficiently as did overexpression of *C/EBPα* ([Figures 2](#fig2){ref-type="fig"}K and 2L; [Figure S2](#mmc1){ref-type="supplementary-material"}D). Together, these data suggest that *ADINR* RNA is inactive in *trans* but that it promotes adipogenesis by activating *C/EBPα* transcription in *cis*.

*ADINR* Interacts with MLL3/4 Complexes to Regulate *C/EBPα* Expression {#sec2.3}
-----------------------------------------------------------------------

In hMSCs, the *PPARγ* promoter is enriched in H3K4me3 and depleted of H3K27me3 ([Figure S3](#mmc1){ref-type="supplementary-material"}A). In contrast, the *C/EBPα* promoter is enriched for overlapping domains of H3K4me3 and H3K27me3, a histone modification pattern associated with "poised/bivalent" regulatory sequences ([@bib1]). During adipogenic differentiation, H3K4me3 is increased markedly on the *C/EBPα* promoter, while H3K27me3 is decreased, suggesting that the *C/EBPα* gene is transcriptionally activated ([Figure 1](#fig1){ref-type="fig"}B). In addition, two other epigenetic markers, histone H3K9me3 and CpG DNA methylation, which are generally associated with gene repression, were present at only low levels and exhibited almost no change during differentiation ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C).

Next, we addressed whether *ADINR* regulates *C/EBPα* by impacting H3K4me3 and H3K27me3 marks at the *C/EBPα* locus. Chromatin immunoprecipitation (ChIP) assays for days 0 and 3 showed that knockdown of *ADINR* significantly reduced H3K4me3 and increased H3K27me3 in the promoter and coding regions of *C/EBPα* ([Figure 3](#fig3){ref-type="fig"}A). This indicates that *ADINR* is involved in the maintenance of H3K4me3 and the removal of H3K27me3 in these regions during adipogenic differentiation. Previous studies in mammals have documented the existence of at least six types of SET-domain-containing lysine methyltransferases that are responsible for H3K4me3 ([@bib24]). These histone methyltransferases interact with a core complex including WDR5 and RBBP5 in order to form a set of three complexes abbreviated as MLL1/2, MLL3/4, and SET1A/B ([Figure S3](#mmc1){ref-type="supplementary-material"}D). To identify which of the complexes is essential for the expression of *C/EBPα* and *ADINR* RNA, we used siRNAs to knock down the specific protein in each of the three complexes (i.e., Menin, PTIP, and WDR82, respectively). Changes in levels of C/EBPα and *ADINR* were then used as readouts for the function of these complexes in regulation of adipogenic transcription. Knockdown of PTIP, a component of the MLL3/4 complexes, significantly reduced the expression of *C/EBPα* and *ADINR* on days 0 and 3 ([Figure S3](#mmc1){ref-type="supplementary-material"}E), while knockdown of Menin and WDR82 had no detectable effect on C/EBPα or *ADINR* expression ([Figures S3](#mmc1){ref-type="supplementary-material"}F and S3G). Knockdown of MLL3 and MLL4 indicated that both proteins are required for *C/EBPα* expression on day 3, whereas only the knockdown of MLL4 markedly altered *C/EBPα* expression on day 0 ([Figures S3](#mmc1){ref-type="supplementary-material"}H and S3I). Collectively, these results point to an association between the MLL3/4 complexes and the regulation of *C/EBPα* and *ADINR* expression. This finding is consistent with previous reports in mouse adipocytes that PTIP and MLL4 are recruited to the *C/EBPα* promoter during preadipocyte differentiation ([@bib5]).

To identify whether there is a molecular relationship between *ADINR* and MLL3/4 complexes, we demonstrated that we could retrieve endogenous *ADINR* RNA by immunoprecipitation of endogenous PTIP and WDR5 from hMSCs on day 3 ([Figure 3](#fig3){ref-type="fig"}B). Subunits of MLL1/2 (Menin) and SET1A/B (CXXC1), however, did not precipitate with *ADINR* RNA. These observations indicate that *ADINR* transcript binds to one or more subunits of the MLL3/4 complex but not MLL1/2 and SET1A/B. To further investigate this interaction of *ADINR* with MLL3/4, we used an RNA pull-down assay that uses in-vitro-transcribed biotin-labeled full-length *ADINR* isoform A and histone H2A mRNA (control) probes. The *ADINR* probe specifically retrieved MLL3/4 subunits (i.e., PTIP, PA1, and WDR5), but not Menin or CXXC1 ([Figure 3](#fig3){ref-type="fig"}C). Together, these results confirm that the *ADINR* RNA associates with the MLL3/4 complexes to regulate *C/EBPα* expression.

PA1 Is Recruited to the *C/EBPα* Promoter by Specifically Binding to *ADINR* {#sec2.4}
----------------------------------------------------------------------------

To identify subunits of MLL3/4 complexes that directly interact with *ADINR*, six forms of in-vitro-purified glutathione S-transferase (GST) fusion protein were used in binding assays with total RNA from adipogenic-induced hMSCs on day 3. In contrast to recombinant GST-RBBP5, GST-WDR5, GST-PTIP, GST-WDR82, and GST-Menin, GST-PA1 was able to specifically bind to the endogenous *ADINR* RNA ([Figure 4](#fig4){ref-type="fig"}A). The functional studies had indicated that *ADINR* RNA regulates the *C/EBPα* gene in *cis*. To confirm that *ADINR* regulates the *C/EBPα* gene by recruiting the MLL3/4 complexes to the *C/EBPα* promoter, we performed ChIP assays on PA1, in the presence or absence of *ADINR*. The results showed that PA1 is recruited to the *C/EBPα* promoter on days 0 and 3, and the knockdown of *ADINR* significantly inhibits the binding of PA1 to the *C/EBPα* promoter ([Figure 4](#fig4){ref-type="fig"}B). These findings indicate that the MLL3/4 complexes are recruited to the *C/EBPα* promoter by the binding of PA1 to *ADINR* RNA during adipogenic differentiation. To localize the PA1 binding site on *ADINR* RNA, seven truncated probes from *ADINR* isoform A were used for GST-PA1 in-vitro-binding assays, ultimately indicating that the PA1-binding activity mapped between nucleotides 1685 and 1937 ([Figure 4](#fig4){ref-type="fig"}C), a region that includes a LINE repeat element conserved in mammals ([Figure S4](#mmc1){ref-type="supplementary-material"}A).

Discussion {#sec3}
==========

In this report, the long intergenic noncoding RNA *ADINR* was found to regulate the adipogenesis of hMSCs by in *cis* recruitment of the trithorax complex (MLL3/MLL4) to the *C/EBPα* promoter region. We show that the abundance of *ADINR* was increased during the differentiation from hMSC to adipocyte. This phenomenon indicates that *ADINR* may play a key role in the complicated process.

It was reported that *C/EBPα* is a critical transcriptional modulator of adipocyte differentiation and adipogenesis ([@bib7]). In this study, downregulation of *ADINR* can downregulate the level of *C/EBPα* via acting on the latter's promoter to impact transcription. Thereby, gene expression cascades involved in adipocytes differentiating into hMSCs are activated and result in adipogenesis. Our findings suggest that *ADINR* is an uncharacterized transcriptional regulator of *C/EBPα*, which shed light on how lncRNA coordinates with key transcriptional factors to regulate downstream gene expression and hMSCs differentiation.

In the human genome, more than 2,000 lncRNAs are bidirectionally transcribed within 2 kb of the transcription start sites of protein-coding genes ([@bib32]). Many of them are co-expressed with the protein-coding genes ([@bib14]). However, the regulatory functions of these lncRNAs that are associated with the promoters or enhancers of protein-coding genes could be different. Several studies have addressed the roles of these promoter-associated antisense transcripts that could directly regulate the expression of nearby genes by various mechanisms ([@bib13], [@bib27]), while other studies have shown that some divergent lncRNAs and protein-coding gene pairs may share the same upstream transcriptional network but contribute to the same cellular response independently ([@bib9], [@bib25]).

Previous mapping of histone marks in embryonic stem (ES) cells has frequently found overlapping domains of H3K4me3 and H3K27me3 at the promoter regions of developmental regulators ([@bib1]). These "bivalent" domains poise the activity of genes encoding developmental transcription factors in pluripotent cells and, during early differentiation, resolve into an H3K4me3-activated state or an H3K27me3-repressed state. During adipogenic differentiation, knockdown of the ADINR dramatically affects the histone marks of both H3K4me3 and H3K27me3 at the promoter of C/EBPα, indicating that the ADINR exerts its functions by modulating this bivalent region. A previous study ([@bib16]) showed that transfection of siRNA may directly regulate chromatin changes by hybridizing to chromatin DNA, which might be an alternative mechanism through which the siRNAs (\#1 and \#2) can directly affect the C/EBPα expression. Although we cannot absolutely exclude this possibility, the consistent results that have been shown by three types of knockdown approaches (siRNA, short hairpin RNA \[shRNA\], and ASO) against ADINR could make it more convincing that this lncRNA plays essential roles in regulating adipogenesis. The precise molecular mechanism that underlies regulation of these specific histone variations is not fully understood, but information from this study clearly implicates the role for this lncRNA.

The MLL3/4 complexes contain a histone H3K27 demethylase (i.e., UTX) that might be responsible for the removal of H3K27me3 at the *C/EBPα* and *ADINR* loci during adipogenic differentiation. Moreover, MLL4 is required for H3K4 mono- and di-methylation and partially redundant with MLL3 during cell differentiation ([@bib22]); at the same time, MLL3/4 plays a critical part in adipogenesis by enriching H3K4me3 on *PPARγ* and *C/EBPα* promoters ([@bib5]). Our findings suggest that the *ADINR* RNA exerts its effect by acting in concert with the functionally uncharacterized PA1 protein so as to serve as a link between the MLL3/4 complexes and the chromatin, thereby activating *C/EBPα* expression ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Recently, the lncRNAs *HOTTIP* ([@bib36]), plus other RNAs with an enhancer-like function ([@bib19], [@bib26]), have been shown to regulate nearby genes in *cis*. Investigation of these RNAs should provide further clues as to whether there is widespread chromatin remodeling associated with RNA recruitment of enzymes that regulate gene expression.

In summary, we identified a lncRNA, named *ADINR*, that functions as a significant positive modulator in hMSC differentiation. Grounded on our findings, we proposed an action model for *ADINR* ([Figure S4](#mmc1){ref-type="supplementary-material"}B). In this model, *ADINR* governs *C/EBPα* transcriptional activity in *cis* by affecting the level of H3K4me3 in the promoter region of *C/EBPα*, and this government occurs through the association of *ADINR* with PA1, which is a member of the histone methylation complex MLL3/4.

Experimental Procedures {#sec4}
=======================

RNA Extraction and Microarray Hybridization {#sec4.1}
-------------------------------------------

The cells on days 0, 3, and 6 during differentiation were harvested, and total RNA was extracted with TRIzol (Invitrogen). Each time point has three replicates. Total RNAs were hybridized using mRNA-lncRNA-combined microarray (CapitalBio).

Plasmids and Antibodies {#sec4.2}
-----------------------

The following plasmids have been used in this study: pCDH-EF1-MSCV-GFP-Puro (SBI, CD711B-1) and pGEX-6P-1 (Addgene). Antibodies: mouse and rabbit immunoglobulin G (IgG) (sc-69786 and sc-66931) were from Santa Cruz Biotechnology. anti-PTIP (A300-369A and A300-370A), anti-PA1 (A301-978A and A301-979A), anti-Menin (A300-105A), and anti-CXXC1 (A303-161A) were ordered from Bethyl Laboratories. anti-WDR5 (ab56919), anti-H3K4me3 (ab8580), and anti-H3K27me3 (ab6002) were from Abcam.

Cell Isolation and Culture {#sec4.3}
--------------------------

Human adipose tissue was obtained from patients undergoing liposuction according to procedures approved by the Ethics Committee at the Chinese Academy of Medical Sciences and Peking Union Medical College. Fresh liposuction tissue was collected, digested, and isolated according to an established method ([@bib3]). The cells were then cultured with hADSC culture medium containing DMEM/F-12, MCDB-201, 2% fetal bovine serum, 1× insulin transferrin selenium, 10^−8^ M dexamethasone, 10^−4^ M ascorbic acid 2-phosphate, 10 ng/ml EGF, 10 ng/ml PDGF-BB, and 1 ng/ml Activin A. See also the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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![lncRNA *ADINR* Is Upregulated during Adipogenic Differentiation\
(A) Mean-centered, hierarchical clustering of 1,423 differentially (≥2-fold) expressed (two-tailed, paired Student's t test, FDR \< 0.2), previously annotated noncoding RNAs on days 0, 3, and 6 of adipogenic differentiation. The microarray data are from three independent biological replicates. NC, negative control.\
(B) ChIP-seq analysis of H3K4me3 and H3K27me3 at the *C/EBPα* and *ADINR* loci in adipose-derived hMSCs on day 20 of adipogenic differentiation relative to the undifferentiated cells (day 0). The data were obtained from the Roadmap Epigenomics Project.\
(C) qRT-PCR analysis of *C/EBPα* and *ADINR* expression across three time points (days 0, 3, and 6) of adipogenic differentiation. The relative expression levels after normalizing to the amount of *GAPDH* signal in each sample are shown. qPCR data are presented as the mean ± SD in three independent experiments.\
(D) 5′ and 3′ RACE and RT-PCR assays detecting full-length *ADINR* RNA in undifferentiated (0d) and 3-day adipogenic-differentiated (3d) hMSCs. The longest bands (arrows) for *ADINR* RNA in the RACE assays were indicated. Through sequencing the PCR product of 5′ RACE, we found that the two shorter bands are non-specific PCR products. +, RT-PCR using DNase-treated 3d total RNA; -, PCR using DNase-treated 3d total RNA (no RT; negative control).\
(E) Single-molecule RNA fluorescence in situ hybridization shows greatly increased abundance of *ADINR* molecules during adipogenic differentiation, and *ADINR* RNA is exclusively localized in the nucleus of hMSCs and day-3 differentiated cells. Scale bars, 50 μm.\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![*ADINR* RNA Depletion Represses Adipogenic Differentiation\
(A and B) qRT-PCR analysis of *ADINR* RNA, *C/EBPα*, and *PPARγ* after knockdown of *ADINR* RNA using two independent siRNAs (si*ADINR*\#1 and si*ADINR*\#2) on day 0 (A) and day 3 (B) of adipogenic differentiation.\
(C) Western blot of *C/EBPα* and *PPARγ* after knockdown of *ADINR* RNA using two independent siRNAs (siADINR\#1 and siADINR\#2) on day 0 and day 3 of adipogenic differentiation.\
(D) Adipogenesis assay of hMSCs (oil red O staining) after knockdown of the *ADINR* (si*ADINR*\#1), *C/EBPα*, and *PPARγ* genes, respectively, on day 6 of adipogenic differentiation (control: scrambled siRNAs).\
(E) qRT-PCR analysis of gene knockdown effects after adipogenesis.\
(F) qRT-PCR analysis of *ADINR* RNA, *C/EBPα*, and *PPARγ* after knockdown of *ADINR* RNA using ASO on day 0 and day 3 of adipogenic differentiation.\
(G) Oil red O staining after knockdown of the *ADINR* using ASO on day 6 of adipogenic differentiation.\
(H) Sequences of the *ADINR* mutant.\
(I) Rescue assay for *ADINR* RNA-deficient adipocytes on day 6 of adipogenic differentiation. The cells were first transfected with the siRNA\#1 for *ADINR* RNA and then infected with lentivirus-expressing mutant *ADINR* RNA and *C/EBPα* mRNA.\
(J) qRT-PCR analysis of *ADINR* and *C/EBPα* expression after adipogenesis.\
(K) Overexpression assay for *ADINR* and *C/EBPα* adipocytes on day 6.\
(L) qRT-PCR analysis of *ADINR* and *C/EBPα* expression after adipogenesis.\
All of the expression levels derived via qPCR were normalized to *GAPDH* and are presented as the means ± SD in three independent experiments. Scale bars, 2 mm.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![*ADINR* RNA Is Required for the Active Chromatin State of the *C/EBPα* and *ADINR* Loci\
(A) ChIP assay of H3K4me3 and H3K27me3 at the *C/EBPα* and *ADINR* loci. The qPCR data are presented as the mean ± SD in six independent experiments. ^∗^p \< 0.05; ^∗∗^p \< 0.01. NC, negative control.\
(B) RNA immunoprecipitation (IP) of endogenous WDR5, PTIP, Menin, and CXXC1 in human adipocytes after 3 days of differentiation. The retrieved RNA was quantified by qRT-PCR (negative controls: U1 and GAPDH RNAs). Approximately 2 μg of cell lysate was loaded as the input control. Error bars represent the mean ± SD in three independent experiments.\
(C) Immunoblot analysis after RNA pull-down assay of in-vitro-transcribed *ADINR* RNA and histone2 mRNA.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![*ADINR* RNA Regulates Active Chromatin via Binding to PA1\
(A) RNA pull-down with six different GST-conjugated proteins (WDR5, WDR82, PA1, PTIP, RBBP5, and Menin) from the adipocyte total RNA on day 3. Only GST-PA1 specifically retrieves *ADINR* RNA.\
(B) ChIP assay of PA1 in the *C/EBPα* promoter region. Knockdown of *ADINR* RNA significantly abrogates the peaks of PA1 occupancy in the region of primers4 and primers5 (see [Figure 3](#fig3){ref-type="fig"}A). ^∗∗^p \< 0.01, Student's t test.\
(C) Affinity of seven truncated ADINR RNA fragments for GST-PA1 (in vitro binding assay). All the panels show means ± SD in three independent experiments.\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}
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